Does Minocycline Improve Recovery After Acute Ischemic Stroke?

医学 安慰剂 米诺环素 改良兰金量表 临床终点 冲程(发动机) 随机对照试验 内科学 中期分析 麻醉 物理疗法 缺血性中风 缺血 机械工程 替代医学 病理 微生物学 生物 工程类 抗生素
作者
Rajinder Singh,Sherwin J. U. Agustin,Marlie Jane,Jocelyn M. Y. Cheong,Sze Haur Lee,Tai Bee Choo
出处
期刊:Journal of stroke medicine [SAGE]
卷期号:2 (1): 40-46 被引量:10
标识
DOI:10.1177/2516608519856263
摘要

Objective: We assessed the efficacy of minocycline in improving outcomes in acute ischemic stroke patients. Method: This was a multicenter, randomized, double-blind, placebo-controlled clinical trial, where acute ischemic stroke patients were randomized to either oral minocycline or placebo within 3 to 48 hours of symptom onset. The primary endpoint was the modified Rankin (mRS) score at day 90. Secondary outcomes included the National Institutes of Health Stroke Scale (NIHSS) scores, the Barthel index, and vascular outcomes at day 90. Results: A total of 139 subjects (73.4% male; mean age 62 [range 19-88] years) were randomized to receive minocycline (n = 69) or placebo (n = 70). At day 90, no significant difference was noted in the proportion of subjects given minocycline with mRS score ≤1 compared to placebo (56% versus 51%). The odds ratio of favorable outcome in the minocycline group compared to placebo was 1.20 (95% CI [0.58, 2.47], P = 0.60). No difference was recorded between the 2 groups in secondary outcomes of the NIHSS score (OR 1.11: 95% CI [0.98, 2.54]), the Barthel index (OR 0.78: 95% CI [0.33, 1.86]), or vascular events (OR 2.09 95% CI [0.29, 23.77]). A planned interim analysis was performed after approximately half the subjects reached the primary endpoint. The data and safety monitoring board recommended ending the trial for futility after determining that it was highly unlikely for minocycline to show significant efficacy over placebo in improving functional outcomes at day 90 if all subjects were randomized. No safety concerns were identified. Interpretation: Oral minocycline administered for acute ischemic stroke was ineffective in improving functional outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈冲发布了新的文献求助10
刚刚
1秒前
1秒前
XZM发布了新的文献求助10
1秒前
Superman发布了新的文献求助10
1秒前
master发布了新的文献求助10
1秒前
CodeCraft的应助被文艺宛筠采纳,获得10
1秒前
1秒前
2秒前
2秒前
byr发布了新的文献求助10
2秒前
2秒前
烟花的应助被13867353624采纳,获得10
2秒前
YihanChen发布了新的文献求助10
3秒前
3秒前
4秒前
instinct发布了新的文献求助10
4秒前
YoungLee发布了新的文献求助10
5秒前
慕青的应助被搞怪文轩采纳,获得10
5秒前
小孟睡不饱完成签到,获得积分10
5秒前
黑米粥发布了新的文献求助200
6秒前
逆水行舟发布了新的文献求助10
6秒前
逆水行舟发布了新的文献求助10
6秒前
逆水行舟发布了新的文献求助10
6秒前
逆水行舟发布了新的文献求助10
6秒前
无花果的应助被野性的苗条采纳,获得10
7秒前
颖颖不吃酸完成签到,获得积分20
7秒前
9秒前
JamesPei的应助被千倾采纳,获得10
10秒前
含蓄凝琴完成签到,获得积分10
10秒前
10秒前
instinct完成签到,获得积分10
10秒前
10秒前
10秒前
renn发布了新的文献求助10
10秒前
zTy完成签到,获得积分10
11秒前
Lucas的应助被初初初啊采纳,获得10
13秒前
13秒前
13秒前
我是老大的应助被水天需采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184008
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829656
捐赠科研通 7781040
什么是DOI,文献DOI怎么找? 3434187
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480658